Yoshiki Seto Selected Research

Neutral Red

12/2021	In chemico sequential testing strategy for assessing the photoallegic potential.
6/2016	Comparative study on prediction performance of photosafety testing tools on photoallergens.
8/2015	Non-animal photosafety screening for complex cosmetic ingredients with photochemical and photobiochemical assessment tools.
8/2015	Phototoxic Risk Assessments on Benzophenone Derivatives: Photobiochemical Assessments and Dermal Cassette-Dosing Pharmacokinetic Study.
9/2011	Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.
8/2010	High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites.
8/2008	Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiki Seto Research Topics

Disease

16	Phototoxic Dermatitis (Phototoxicity) 12/2021 - 08/2008
4	Inflammation (Inflammations) 03/2018 - 09/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 06/2017
3	Colitis 07/2018 - 04/2017
2	Photoallergic Dermatitis (Photoallergy) 12/2021 - 10/2009
2	Achlorhydria (Hypochlorhydria) 04/2018 - 01/2017
2	Body Weight (Weight, Body) 04/2017 - 01/2011
2	Idiopathic Pulmonary Fibrosis 06/2013 - 03/2013
1	Hypertriglyceridemia 05/2018
1	Pain (Aches) 01/2018
1	Necrosis 04/2017
1	Wounds and Injuries (Trauma) 04/2017
1	Hypothermia 02/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2013
1	Pneumonia (Pneumonitis) 06/2013

Drug/Important Bio-Agent (IBA)

7	Neutral RedIBA 12/2021 - 08/2008
7	Pharmaceutical PreparationsIBA 10/2021 - 08/2008
7	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016 - 08/2008
3	AntigensIBA 03/2018 - 06/2013
3	DNA (Deoxyribonucleic Acid)IBA 03/2013 - 08/2010
2	Peroxidase (Myeloperoxidase)IBA 07/2018 - 06/2017
2	tranilastIBA 07/2018 - 06/2017
2	Ethanol (Ethyl Alcohol)IBA 06/2017 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2013
2	pirfenidoneIBA 06/2013 - 03/2013
2	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 09/2011 - 09/2010
1	Peptides (Polypeptides)IBA 12/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 07/2018
1	Corn Oil (Oil, Corn)IBA 05/2018
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2018
1	Meloxicam (Mobic)FDA LinkGeneric 01/2018
1	Fenofibrate (CiL)FDA LinkGeneric 08/2017
1	SolutionsIBA 06/2017
1	AcidsIBA 06/2017
1	Cilostazol (Pletal)FDA LinkGeneric 04/2017
1	isoquercitrinIBA 04/2017
1	AntioxidantsIBA 04/2017
1	Dextrans (Dextran)FDA Link 04/2017
1	InterleukinsIBA 04/2017
1	Thioctic Acid (Lipoic Acid)IBA 04/2017
1	SodiumIBA 04/2017
1	CytokinesIBA 04/2017
1	ChemokinesIBA 04/2017
1	Drinking WaterIBA 04/2017
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2017
1	Leucine (L-Leucine)FDA Link 01/2016
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2016
1	Dosage Forms (Dosage Form)IBA 01/2016
1	Plant ExtractsIBA 08/2015
1	benzophenoneIBA 08/2015
1	Ketoprofen (Orudis)FDA LinkGeneric 08/2015
1	PowdersIBA 06/2013
1	Intercalating AgentsIBA 09/2011
1	flavoneIBA 09/2011
1	FluoroquinolonesIBA 09/2011
1	Amyloid (Amyloid Fibrils)IBA 09/2011
1	nobiletinIBA 09/2011
1	Bufexamac (Jomax)IBA 06/2011
1	CyclodextrinsIBA 06/2011
1	Nicotine FDA Link 01/2011
1	CotinineIBA 01/2011
1	Griseofulvin (Grifulvin V)FDA LinkGeneric 09/2009

Therapy/Procedure

6	Oral Administration 10/2021 - 09/2009
1	Enema (Enemas) 06/2017
1	Respiratory Therapy (Therapy, Respiratory) 01/2016